Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz

February 9, 2024
Amgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared HolzAmgen has ‘a lot to prove’ in the weight-loss drug category, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho, joins ‘Closing Bell Overtime’ to talk Amgen’s obesity drug trial results.


 

Latest Mizuho News

See all news
Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

May 8, 2026
Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

April 29, 2026
All eyes on Coinbase after Robinhood's crypto revenue falls 47%

All eyes on Coinbase after Robinhood's crypto revenue falls 47%

May 5, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue